The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arjan Lalchandani
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Arjan Lalchandani, the promoter and Managing Director of Dr Lalchandani Labs Ltd, has sold 1,00,000 equity shares (2.31% of total share capital) through open market between June 4 and June 9, 2025. His stake in the company has come down from 17,22,851 shares (39.76%) to 16,22,851 shares (37.45%). The total share capital of the company stands at Rs. 4,33,30,680. The disclosure was filed under Regulation 29(2) of the SEBI Takeover Regulations, 2011, which is mandatory when a promoter changes their shareholding.
This is a mild negative signal for retail investors as the promoter is reducing his stake, which may raise concerns about confidence in the company. However, the sale size is relatively small (2.31%), and the promoter remains the largest shareholder at 37.45%, so the price impact should be limited.